Wednesday, April 15, 2009

Genentech - Levinson out, Soriot in

Art Levinson is to step down from his role as Genentech’s CEO but will play “an active role” at the company as part of Roche’s attempts to integrate and retain the biotech’s key staff.

The integration plan will result in several Roche employees taking up positions within Genentech, including Pascal Soriot, currently head of commercial operations at Roche, who will replace Levinson as CEO.

No comments: